Topiramate Tablet, Film Coated
Product Images NDC 68071-5165

4 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68071-5165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of topiramate, showing its molecular framework including rings and functional groups such as sulfonamide and ether moieties.*
FDA Label Image

Figure-1jpg (Figure 1)

Figure-1jpg (Figure 1)
A line graph comparing cumulative rates for time to first seizure over 500 days for Topiramate at doses of 50 mg/day and 400 mg/day. The y-axis represents cumulative rates, while the x-axis shows time in days. Two lines indicate differences in seizure rates between the two dosage groups, with a p-value of 0.0002 noted on the graph.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar graph showing the change from baseline to double-blind phase in average monthly migraine period rate, comparing placebo and Topamax (topiramate) at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Data are presented for two studies (Study 11 and Study 12) with error bars indicating standard error. Statistical significance indicators for p-values are shown below the graph.*
FDA Label Image

Pdp (68071 5165 6)

Pdp (68071 5165 6)
Topiramate 50 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates a package size of 60 film-coated oral tablets. It includes multiple barcodes, the product number R1861060, and storage instructions specifying controlled temperatures between 59-86°F. Manufacturer information notes Sun Pharmaceutical Ltd., Maharashtra, India. The label also features warnings to keep out of reach of children and references to see the manufacturer's label for a full list of ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.